Efficacy and Safety of Sodium Oxybate in Isolated Focal Laryngeal Dystonia:A Phase IIb Double-Blind Placebo-Controlled Cross-Over Randomized Clinical Trial
Ann Neurol 97:329-343, Simonyan,K.,et al, 2025
Gamma-Hydroxybutyric Acid for Treatment of Alcohol Withdrawal Syndrome
Lancet 2:787-789, Gallimberti,L.,et al, 1989
Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024
Antibody-Mediated Encephalitis
NEJM 378:840-851, Dalmau, J.,et al, 2018
Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017
Investigations in GABA? Receptor Antibody-Associated Encephalitis
Neurol 88:1012-1020,1010, Spatola, M.,et al, 2017
An Older Man with Memory Impairment and Convulsions
BMJ 358:J2824, Zhao, X.,et al, 2017
Paraneoplastic and Autoimmune Encephalitis
UptoDate July, Dalmau, J.,et al, 2017
Cerebral Palsy
Lancet 383:1240-1248, Colver, A.,et al, 2014
The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014
Encephalitis and GABAb Receptor Antibodies
Neurol 81:1500-1506, H�ftberger, R.,et al, 2013
Treatment of ?-Aminobutyric Acid� Receptor-Antibody Autoimmune Encephalitis with Oral Corticosteroids
Arch Neurol 69:1061-1063, Goldenholz, D.M.,et al, 2012
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Neurol 77:179-189, Lancaster, E.,et al, 2011
Practice Parameter: The Diagnostic Evaluation and Treatment of Trigeminal Neuralgia (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the AAN & EFNS
Neurol 71:1183-1190, Gronseth,G.,et al, 2008
Narcolepsy With Cataplexy
Lancet 369:499-511, Dauvilliers,Y.,et al, 2007
Cerebral Palsy
Lancet 363:1619-1631, Koman,L.A.,et al, 2004
Stiff-Person Syndrome
The Neurologist 10:131-137, Murinson,B.B., 2004
Intrathecal Baclofen Withdrawal Mimicking Sepsis
J Emerg Med 24:423-427, Kao,L.W.,e tal, 2003
Baclofen Treatment in Tourette Syndrome
Neurol 56:599-604, Singer,H.S.,et al, 2001
Intrathecal Baclofen for the Treatment of Dystonia in Patients with Reflex Sympathetic Dystrophy
NEJM 343:625-630,654, van Hilten,B.J. et al, 2000
The Stiff-Person Syndrome:An Autoimmune Disorder Affecting Neurotransmission of y-Aminobutyric Acid
Ann Int Med 131:522-530, Levy,L.M.,et al, 1999
Review of 23 Patients Affected by the Stiff Man Syndrome:Clinical Subdivision into Stiff Trunk (man) Syndrome,Stiff Limb Syndrome,and Progressive Encephalopmyelitis with Rigidity
JNNP 65:633-640, Barker,R.A.et al, 1998
A Double-Blind Controlled Study of Gabapentin and Baclofen as Treatment for Acquired Nystagmus
Ann Neurol 41:818-825, Averbuch-Heller,L.,et al, 1997
Intrathecal Baclofen Therapy in Stiff-Man Syndrome:A Double-blind, Placebo-controlled Trial
Neurol 45:1893-1897, Silbert,P.L.,et al, 1995
Stiff-Man Syndrome Treated with Intrathecal Baclofen
Neurol 43:2412, Penn,R.D.&Mangieri,E.A., 1993
Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin
JAMA 270:2475-2477, Albright,A.L.,et al, 1993
Surgical Management of Spastic Diplegia in Cerebral Palsy
NEJM 326:745-749, Park,T.S.&Owen,J.H., 1992
Low Cerebrospinal Fluid Concentration of Free Gamma-Aminobutyric Acid in Startle Disease
Lancet 340:80-81, Dubowitz,L.M.S.,et al, 1992
Intrathecal Baclofen for Spasticity in Cerebral Palsy
JAMA 265:1418-1422, Albright,A.L.,et al, 1991
Intrathecal Baclofen for Intractable Axial Dystonia
Neurol 41:1141-1142, Narayan,R.K.,et al, 1991
Vigabatrin
Editorial, Lancet 1:532-5331989., , 1989
Intrathecal Baclofen for Severe Spinal Spasticity
NEJM 320:1517-1521, 1553-15551989., Penn,R.D.,et al, 1989
Intrathecal Baclofen for Long-Term Treatment of Spasticity:A Multi-Centre Study
JNNP 52:933-939, Ochs,G.,et al, 1989
Baclofen for Intractable Hiccups
NEJM 319:1354, Burke,A.M.,et al, 1988
Glossopharyngeal Neuralgia:Successful Treatment with Baclofen
Ann Neurol 21:514-515, Ringel,R.A.&Roy,E.P., 1987
Baclofen in the Treatment of Trigeminal Neuralgia:Double-Blind Study & Long-Term Follow-up
Ann Neurol 15:240-244, Fromm,G.H.,et al, 1984
Efficacy of a Combination of Sodium Valproate & Baclofen in Meige's Disease (idiopathic orofacial dystonia)
BMJ 285:853, Brennan,M.J.W.,et al, 1982
Baclofen in the Treatment of Stiff-Man Syndrome
Ann Neurol 9:511-512, Miller,F.,et al, 1981
Spasticity
et al (Part 1 & 2) NEJM 304:28-33, 96-99., Young,R.R., 1981
Baclofen in Treatment of the"Stiff-Man Syndrome
Arch Neurol 37:600-601, Whelan,J.L., 1980
Isoniazid Therapy of Huntington Disease
Neurol 29:370-375, Perry,T.L.,et al, 1979
Baclofen for Spasticity in Multiple Sclerosis
Neurol 28:1094-1098, Feldman,R.G.,et al, 1978
Treatment of Huntington's Chorea with Isoniazid
NEJM 297:840, 1977. (Letter), Perry,T.L.,et al, 1977
Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation
NEJM 392:1749-1751, Gorey,S., 2025
Aspirin Continuation or Discontinuation in Surgically Treated Chronic Subdural Hematoma, A Randomized Clinical Trial
JAMA Neurol 82:551-559, Kamenova,M.,et al, 2025
Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025
AAV9-Mediated Gene Therapy for Infantile-Onset Pompes Disease
NEJM 392:2438-2446, 2477, Ma,X.,et al, 2025
Outcomes of Patients with Embolic Stroke of Undetermined Source Treated with Antiplatelet Agents or Anticoagulation, A Multicenter Cohort Study
Neurol 105: e213876, Seigler,J.E.,et al, 2025
Clinicopathologic conference, Malignant Mixed Germ-Cell Tumor and Anti-NMDA Receptor Encephalitis
NEJM 303:488-496, Case 22-2025, 2025